Daniel Schultz to Hepatoblastoma
This is a "connection" page, showing publications Daniel Schultz has written about Hepatoblastoma.
Connection Strength
0.059
-
Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. J Med Chem. 2024 Sep 26; 67(18):16270-16295.
Score: 0.059
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.